Dugel Pravin

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 54% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Dugel Pravin's trades of Ocular Therapeutix, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
343.54
Quantity 8,031
Value US$2,130,682
Transaction date
Proposed sale
Price
8.20
Quantity 21,156
Value US$173,513
Transaction date
Proposed sale
Price
8.28
Quantity 20,056
Value US$166,086
Transaction date
Proposed sale
Price
9.04
Quantity 124,882
Value US$1,128,584
Transaction date
Proposed sale
Price
12.04
Quantity 19,530
Value US$235,083
Transaction date
Proposed sale
Price
12.04
Quantity 21,494
Value US$258,758
Transaction date
Proposed sale
Price
7.18
Quantity 21,219
Value US$152,289
Transaction date
Proposed sale
Price
6.87
Quantity 21,475
Value US$147,617
Transaction date
Proposed sale
Price
9.01
Quantity 17,783
Value US$160,186
Transaction date
Proposed sale
Price
9.01
Quantity 2,897
Value US$26,095
Transaction date
Proposed sale
Price
9.02
Quantity 20,880
Value US$188,271
Transaction date
Proposed sale
Price
5.79
Quantity 21,626
Value US$125,150
Transaction date
Sale
Price
6.34
Quantity 28,301 -40.4%
Value US$179,428
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-26 2026-08-24
S Sale
52,456 +35.2%
271.74
US$4,891,970 		52,456 +35.2% 271.74 US$4,891,970
2026-08-24 2026-08-24
PrS Proposed sale
8,031
343.54
US$2,130,682 		8,031 343.54 US$2,130,682
2026-05-28 2026-05-26
S Sale
49,456 -30.2%
356.24
US$1,329,891 		49,456 -30.2% 356.24 US$1,329,891
2026-05-26 2026-05-26
PrS Proposed sale
21,156
8.20
US$173,513 		21,156 8.20 US$173,513
2026-02-25 2026-02-23
S Sale
20,056 -0.7%
8.28
US$166,064 		20,056 -0.7% 8.28 US$166,064
2026-02-23 2026-02-23
PrS Proposed sale
20,056
8.28
US$166,086 		20,056 8.28 US$166,086
2026-02-17 2026-02-12
S Sale
124,882 -4.0%
9.04
US$1,128,933 		124,882 -4.0% 9.04 US$1,128,933
2026-02-12 2026-02-12
PrS Proposed sale
124,882
9.04
US$1,128,584 		124,882 9.04 US$1,128,584
2025-11-26 2025-11-24
S Sale
19,530 -0.6%
12.04
US$235,141 		19,530 -0.6% 12.04 US$235,141
2025-11-24 2025-11-24
PrS Proposed sale
19,530
12.04
US$235,083 		19,530 12.04 US$235,083
2025-08-27 2025-08-25
S Sale
21,494 -0.7%
12.04
US$258,788 		21,494 -0.7% 12.04 US$258,788
2025-08-25 2025-08-25
PrS Proposed sale
21,494
12.04
US$258,758 		21,494 12.04 US$258,758
2025-05-27 2025-05-23
S Sale
21,219 -0.6%
7.18
US$152,352 		21,219 -0.6% 7.18 US$152,352
2025-05-23 2025-05-23
PrS Proposed sale
21,219
7.18
US$152,289 		21,219 7.18 US$152,289
2025-02-26 2025-02-24
S Sale
21,475 -0.6%
6.87
US$147,533 		21,475 -0.6% 6.87 US$147,533
2025-02-24 2025-02-24
PrS Proposed sale
21,475
6.87
US$147,617 		21,475 6.87 US$147,617
2024-11-27 2024-11-25
S Sale
20,680 -2.5%
9.01
US$186,327 		20,680 -2.5% 9.01 US$186,327
2024-11-25 2024-11-25
PrS Proposed sale
17,783
9.01
US$160,186 		17,783 9.01 US$160,186
2024-11-25 2024-11-25
PrS Proposed sale
2,897
9.01
US$26,095 		2,897 9.01 US$26,095
2024-08-27 2024-08-23
S Sale
20,880 -2.5%
9.02
US$188,338 		20,880 -2.5% 9.02 US$188,338
2024-08-23 2024-08-23
PrS Proposed sale
20,880
9.02
US$188,271 		20,880 9.02 US$188,271
2024-05-28 2024-05-23
S Sale
21,626 -2.5%
5.79
US$125,215 		21,626 -2.5% 5.79 US$125,215
2024-05-23 2024-05-23
PrS Proposed sale
21,626
5.79
US$125,150 		21,626 5.79 US$125,150
2021-04-05 2021-04-05
S Sale
28,301 -40.4%
6.34
US$179,428 		28,301 -40.4% 6.34 US$179,428